Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: A longitudinal study

• Main Authors: Ng T., Lee Y.Y., Chae J.-W., Yeo A.H.L., Shwe M., Gan Y.X., Ng R.C.H., Chu P.P.Y., Khor C.C., Ho H.K., Chan A.
• Other Authors: PHARMACY
• Format: Article
• Published: 2020
• Subjects: antineoplastic agent; brain derived neurotrophic factor; scatter factor receptor; brain-derived neurotrophic factor, human; adult; Article; breast cancer; cancer chemotherapy; cancer staging; clinical evaluation; cognition; cognitive defect; cohort analysis; concentration loss; disease association; enzyme linked immunosorbent assay; functional assessment; Functional Assessment of Cancer Therapy Cognitive Function; gene frequency; genetic polymorphism; genotype; heterozygote; homozygosity; human; longitudinal study; major clinical study; middle aged; pilot study; prospective study; protein blood level; questionnaire; Sanger sequencing; self report; aged; blood; breast tumor; chemically induced; female; genetic association study; genetic predisposition; genetics; male; pathology; single nucleotide polymorphism; Adult; Aged; Brain-Derived Neurotrophic Factor; Breast Neoplasms; Cognitive Dysfunction; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Neoplasm Staging; Polymorphism, Single Nucleotide
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175411
• Institution: National University of Singapore

10.1186/s12885-017-3861-9